December 10, 2017 10:32 AM ESTUpdated December 11, 04:19 PM

#ASH17: How does Novartis’ Kymriah DLBCL data stack up heading straight to a CAR-T showdown with Gilead?

Novartis turned up at ASH with 6-month data for their pioneering CAR-T Kymriah that puts them on the inside track to a quick and near …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

#ASH17: How does No­var­tis’ Kym­ri­ah DL­B­CL da­ta stack up head­ing straight to a CAR-T show­down with Gilead?